Muna Therapeutics is a clinical-stage biotech pioneering small-molecule therapies for neurodegenerative diseases like Alzheimer’s and Parkinson’s. By targeting protein misfolding and mitochondrial dysfunction, its platform aims to slow disease progression. Researchers and pharmaceutical partners leverage these novel compounds to develop disease-modifying treatments, ultimately benefiting patients and caregivers seeking alternatives to symptomatic care.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends